The Real U.S. Trademark Risk Is Usually Buried on the Day You File

In August 2025, the United States Patent and Trademark Office (USPTO) carried out a concentrated enforcement action against improper filings, terminating tens of thousands of trademark applications and registration records at once.

For many Chinese outbound companies, this was not a sudden event. It was a reckoning years overdue.

In the matters we handle, the same pattern recurs: a company has proven its business model, built stable cash flow, completed brand registry on Amazon and other platforms, and accumulated years of goodwill and reviews — only to have risk surface all at once, years later, because of how its trademark was filed.

These problems do not arise in the present.

They were buried years earlier.

I. Why Does the Risk Always Surface "After Success"?

In the early stage of building a brand, many companies — weighing cost and speed — choose providers that are inexpensive, fast, and promise "guaranteed approval" with "specimens included."

The mark is granted and used continuously for years. No opposition, no complaint, no dispute. So almost no one questions its validity.

Until, years later, regulators intervene — or a competitor makes trouble.

When a particular attorney, filing route, or agency model is found to involve systemic serious violations, the cleanup is typically not case by case. It happens all at once.

Large numbers of applications and registrations handled through that route are terminated or cancelled wholesale, and only then does a company realize that the trademark rights underpinning years of investment are exposed to challenge — or loss.

And when a mark used for years suddenly fails, it bears directly on core operations, listing ASINs, brand registry, and business continuity.

II. What Are the Real Baselines for a U.S. Trademark Application?

As a matter of U.S. trademark law, while obtaining a registration requires examination on likelihood of confusion, descriptiveness, and more, the baseline requirements are simple and clear — three points:

• First, a genuine applicant.
• Second, genuine specimens of use.
• Third, a genuine signature executed by the attorney personally, with the attorney taking responsibility for it.

If the mark is already in commercial use, a federal application may be filed on a use basis.

If it is not yet in use, an intent-to-use (ITU) application may be filed, with registration following only after acceptable specimens are submitted.

Where a foreign application exists, filing under Section 44(d) or 44(e) is also available.

III. Why "Off-the-Shelf Registered Marks" Became a Systemic Risk

The origins of the trade in "off-the-shelf registered marks" are hard to trace.

Early on, the phenomenon may have amounted to competition over filing speed and examination timelines. It then evolved into supplying the market with completed registrations available for immediate use.

In some of these routes, the application process became highly proceduralized:

• identity documents or business licenses of unclear provenance;
• specimens formally complete but of questionable authenticity;

filed through a "borrowed" U.S. attorney's USPTO account.

In that process, a trademark ceases to be a right requiring continued use and long-term maintenance, with responsibility shared by the owner and counsel, and becomes instead an "off-the-shelf asset" to be delivered and transferred quickly.

When the regulatory posture changes, routes like these are the first to be hit.

IV. The USPTO's Enforcement Logic: Why the Sweeps?

In August 2025, the USPTO announced sanctions against offshore filing operations and terminated large numbers of related applications and registrations.

Before that, the USPTO had already been issuing show-cause proceedings against many China-origin applications, and the industry had taken notice.

These actions were not isolated. The regulatory focus is consistent:

• whether the filing was genuinely authorized;
• whether the attorney's signature was executed personally;
• whether counsel of record actually participated in the matter;
• whether the specimens are genuine and credible.

Case Study 1 | Collateral Exposure From an Attorney-Authenticity Problem

In one matter we handled, the client's U.S. applications involved no fabricated use and no applicant problem — but because the U.S. attorney involved was caught up in a well-known authenticity controversy, the applications were swept up and suspended by the USPTO, unable to proceed.

At that point the question was no longer whether the marks were registrable, but whether the filing route could be re-verified and cleared.

We reviewed every affected mark for applicant identity, chain of authorization, signature method, and the source of specimens. Having confirmed no substantive defects, we assisted the client in systematically clearing the issue through procedural filings and restoring examination.

After nearly two years of suspension, that group of marks returned to normal examination and ultimately registered.

The experience confirms a reality: under the current regulatory environment, even where the mark itself is sound, a flawed filing route can surface all at once years later.

V. Attorney of Record in Name vs. Genuine Participation

In 2019 the USPTO implemented the rule requiring foreign applicants to be represented by a licensed U.S. attorney, with the aim of improving filing quality and curbing systemic improper filings.

In the market, however, the problem is not whether an attorney's name appears — it is whether the attorney genuinely participated.

Common situations include:

• the attorney turning over a USPTO account to an intermediary;
• non-attorney personnel completing and submitting the materials directly;
• the attorney never actually reviewing the materials or verifying their authenticity, yet executing a purported "signature."

Once such filings enter an audit, an adversary's challenge, or a sweep, the related ITU applications, registrations, and even existing rights may be terminated or cancelled outright.

VI. Specimens: The Most Overlooked and Most Fatal Element

The USPTO has repeatedly explained the harm "specimen farms" do to the trademark system: manufacturing, compositing, or staging evidence that appears to show use, in order to satisfy the formal requirements for registration or maintenance.

Such problems rarely surface at filing. They surface after the mark has been used in commerce, entered into platform brand registry, deployed in advertising, or made the subject of licensing negotiations — at which point audit, opposition, or cancellation proceedings create risk that cannot be ignored.

Case Study 2 | Exiting Without Loss and Rebuilding After Specimen Defects

In another matter, some of a client's marks faced opposition and cancellation proceedings brought by a third party because of historical specimen defects.

On assessment, we concluded that continuing to litigate the merits around marks carrying evidentiary risk would magnify the client's overall exposure and did not serve its long-term interests.

After full consultation with the client, we assisted in relinquishing the individual marks with specimen defects in an orderly way — through procedural filings including a consent to judgment — without disturbing the core brand portfolio, while simultaneously replanning and advancing a compliant filing route.

The client thereby avoided unnecessary merits litigation costs and achieved both a clean break from the risk and a rebuilt system, preserving continuity and control over its later trademark strategy.

VII. The Real Risk Is Not "Whether It Can Register"

Under the U.S. trademark system, risk does not arise only from whether a mark can be approved. More often it arises from defects in the filing route, the chain of authorization, the attorney's signature, and the specimens.

Once an audit, an adversary's challenge, or a sweep begins, that risk tends to surface all at once and to bear directly on a company's brand and business continuity.

That is why a low-cost, results-oriented registration route has today become the high-risk route.

This article addresses general legal questions only and does not constitute legal advice on any specific matter. Outcomes depend on the specific facts, evidence, applicable law, and the court's discretion.